DRUG LIST 7

SYNTHROID

LEVOTHYROXINEClass: T4 Synthetic Hormone

Replacement

IFU: Hypothyroidism

LEVOXYL

LEVOTHYROXINE

Class: T4 Synthetic Hormone Replacement

IFU: Hypothyroidism

GLUCOPHAGE

METFORMIN

Class: Biguanide

IFU: Type 2 Diabetes

ACTOS

PIOGLITAZONE

Class: Thiazolidinedione

IFU: Type 2 Diabetes

AMARYL

GLIMEPIRIDE

Class: Sulfonylurea

IFU: Type 2 Diabetes

DIABETA

GLYBURIDE

Class: Sulfonylurea 2nd Generation

IFU: Type 2 Diabetes

GLUCOTROL

GLIPIZIDE

Class: Sulfonylurea 2nd Generation

IFU: Type 2 Diabetes

JANUVIA

SITAGLIPTIN

Class: Dipeptidyl peptidase- 4 inhibitor

IFU: Type 2 Diabetes

LANTUS

INSULINE GLARGINE

Class: Long Acting Insulin

IFU: Type 1 (Adults and Children) Type 2 (Adults)

NOVOLOG

INSULIN ASPART

Class: Short Acting InsulinIFU: Diabetes –SC

injection, continuous subcutaneous insulin

infusion (SCII), IV infusion

HUMALOG

INSULIN LISPRO

Class: Short Acting Insulin

IFU: Diabetes –SC injection, continuous subcutaneous insulin

infusion pump

FOSAMAX

ALENDRONATE

Class: Bisphosphonate

IFU: Treatment of postmenopausal osteoporosis and

osteoporosis in men

BONIVA

IBANDRONATE

Class: Bisphosphonate

IFU: Prevention and treatment of post-

menopausal osteoporosis

ACTONEL

RISEDRONATEClass: Bisphosphonate

IFU: Prevention and treatment of postmenopausal osteoporosis and

glucocorticoid induced osteoporosis (men & women). Treatment to increase bone

mass in men with osteoporosis. Treatment of Paget’s disease of bone.

YAZ

DROSPIRENONE / ETHINYL ESTRADIOL

Class: Progestin & Estrogen

IFU: Treatment of premenstrual disphoric disorder in women who choose an oral contraceptive as

the method of birth control

ORTHO TRICYCLEN

ETHINYL ESTRADIOL / NORGESTIMATE

Class: Progestin & Estrogen

IFU: Moderate acne vulgaris in females at or older than 15 years of age, who have no

known contraindications to oral contraceptive therapy, desire contraception, have achieved

menarche, and are unresponsive to topical anti-acne medications.

PREMARIN

CONJUGATED ESTROGENS

Class: Estrogen

IFU: Moderate to severe vasomotor symptoms of menopause. Vulvar and

vaginal atrophy. Osteoporosis prevention (consider alternative treatments). Hypoestrogenism

EVISTA

RALOXIFENE HCL

Class: Selective estrogen receptor modulator (SERM)

IFU: Prevention and treatment of osteoporosis in postmenopausal

women

FLOMAX

TAMSULOSIN HCL

Class: Alpha 1A- Blocker

IFU: BPH

PROSCAR

FINASTERIDEClass: Type II 5a- reductase inhibitor

IFU: BPH, to improve symptoms and reduce risks of acute urinary retention

and need for prostate surgery. To reduce risk of symptomatic progression of BPH,

with doxazosin

AVODART

DUTASTERIDEClass: Type I and II 5a- reductase inhibitor

(cGMP-specific)

IFU: BPH, as monotherapy to improve symptoms and reduce risks of acute

urinary retention and need for prostate surgery, or in combination with tamsulosin

VIAGRA

SILDENAFIL CITRATE

Class: Phosphodiesterase type 5 inhibitor (cGMP-

specific)

IFU: Erectile dysfunction

CIALIS

TADALAFIL

Class: Phosphodiesterase type 5 inhibitor (cGMP-

specific)

IFU: Erectile dysfunction

LEVITRA

VARDENAFILClass: Phosphodiesterase type 5

inhibitor (cGMP-specific)

IFU: Erectile dysfunction

ADIPEX

PHENTERMINEClass: Sympathomimetic

IFU: Short-term monotherapy as adjunct. In management of exogenous obesity in

patients with initial body mass at or above 30kg/m2, or at or above 27kg/m2

in presence of other risk factors